目标:我们试图确定与学术外科职业相关的保费,通过归一化到功相对值单位(wRVU)的补偿来衡量。
背景:学术外科生涯,体现创新和指导,提供内在的奖励,但没有很好的货币化。我们知道学术外科医生的薪酬低于非学术外科医生,但是临床努力的价值,归一化为wRVU,学术和非学术外科医生之间的特征还没有得到很好的描述。因此,我们分析了2010年至2022年学术和非学术外科工作的估值差异.
方法:我们利用2010年、2014年、2018年和2022年的医疗集团管理协会提供者薪酬数据来比较学术和非学术外科医生。我们分析了原始总现金补偿(TCC),wRVU,每个wRVU的TCC(TCC/wRVU),和TCC到集合(TCCtColl)。我们计算了每个wRVU的集合(Coll/wRVU)。我们使用消费者价格指数调整了TCC和TCCtColl的通货膨胀。进行了用于趋势分析的线性建模。
结果:与非学术相比,学术外科医生的TCC较低(2010年:500,415.0±23,666美元与631,515.5±23,948.2美元,-21%;2022年:564,789.8±23,993.9美元,而$628,247.4±15,753.2,-10%),尽管wRVU较高(2022:9,109.4±474.9vs.8,062.7±252.7)和更高的Coll/wRVU(2022年:76.68±8.15vs.71.80±6.10)。趋势分析表明,TCC将在2038年收敛,估计为660,931美元。
结论:2022年,学术外科医生拥有更多的临床活动和优越的组织收入获取,尽管总体和正常化的临床补偿较少。基于TCC/wRVU,学术界收取的费用比非学术手术高出16%。然而,趋势分析表明,TCC将在未来20年内收敛。
OBJECTIVE: We sought to determine the premium associated with a career in academic surgery, as measured by compensation normalized to the work relative value unit (wRVU).
BACKGROUND: An academic surgical career embodying innovation and mentorship offers intrinsic rewards but is not well monetized. We know compensation for academic surgeons is less than their nonacademic counterparts, but the value of clinical effort, as normalized to the wRVU, between academic and nonacademic surgeons has not been well characterized. Thus, we analyzed the variations in the valuation of academic and nonacademic surgical work from 2010 to 2022.
METHODS: We utilized Medical Group Management Association Provider Compensation data from 2010, 2014, 2018, and 2022 to compare academic and nonacademic surgeons. We analyzed raw total cash compensation (TCC), wRVU, TCC per wRVU (TCC/wRVU), and TCC to collections (TCCtColl). We calculated collections per wRVU (Coll/wRVU). We adjusted TCC and TCCtColl for inflation using the Consumer Price Index. Linear modeling for trend analysis was performed.
RESULTS: Compared with nonacademic, academic surgeons had lower TCC (2010: $500,415.0±23,666 vs $631,515.5±23,948.2, -21%; 2022: $564,789.8±23,993.9 vs $628,247.4±15,753.2, -10%), despite higher wRVUs (2022: 9109.4±474.9 vs 8062.7±252.7) and higher Coll/wRVU (2022: 76.68±8.15 vs 71.80±6.10). Trend analysis indicated that TCC will converge in 2038 at an estimated $660,931.
CONCLUSIONS: In 2022, academic surgeons had more clinical activity and superior organizational revenue capture, despite less total and normalized clinical compensation. On the basis of TCC/wRVUs, academia charges a premium of 16% over nonacademic surgery. However, trend analysis suggests that TCC will converge within the next 20 years.